Follow the 파마리서치 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 파마리서치 has published 31 reports. Market capitalisation: €3,870.1bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: PolishCompanyLimited. All data is openly available.
31
Insider Decl.
n/a
Thresholds
€58,404
6 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 파마리서치 Strong Buy (bullish), based on 14 analysts. Average price target: ₩490,500.
11Σ signal
Buys €58,404n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,625 of 28,016 companies
71.5
score / 100
Value
51
Quality
92
FCF yld3.8%
Earn yld4.3%
EV/EBITDA16.0x
ROE27%
Gross mgn77%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
파마리서치 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the research and development of innovative pharmaceutical solutions.